Pharmacologic control of heart rate in atrial fibrillation

Cardiology Clinics

Volumn 14, Issue 4, 1996, Pages 521-536

  Falk, R H ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; ESMOLOL; FLECAINIDE; PROPAFENONE; PROPRANOLOL; SOTALOL; VERAPAMIL;

ANKLE EDEMA; ARRHYTHMOGENESIS; CLINICAL TRIAL; EXERCISE TOLERANCE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RATE; HUMAN; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SINUS RHYTHM; TORSADE DES POINTES;

EID: 0029829741     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70301-5     Document Type: Article

References (71)

1. J. Abrams J. Allen D. Allin Efficacy and safety of esmolol versus propranolol in the treatment of supraventricular tachyarrhythmias: A multicenter double-blind clinical trial Am Heart J 110 1985 913 922
2. J.L. Anderson E.M. Gilbert B.L. Alpert Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy: A multicenter, double-blinded, crossover study of flecainide and placebo with transtelephonic monitoring Circulation 80 1989 1557 1570
3. S. Anderson L. Blansky R. Byrd Comparison of the efficacy and safety of esmolol, a short-acting beta-blocker, with placebo in the treatment of supraventricular tachyarrhythmias Am Heart J 111 1986 46 48
4. J.E. Atwood J. Myers M. Sullivan Maximal exercise testing and gas exchange in patients with chronic atrial fibrillation J Am Coll Cardiol 11 1988 508 513
5. J.E. Atwood J.N. Myers M.J. Sullivan Diltiazem and exercise performance in patients with chronic atrial fibrillation Chest 93 1988 20 25
6. J.E. Atwood M. Sullivan S. Forbes Effect of beta-adrenergic blockade on exercise performance in patients with chronic atrial fibrillation J Am Coll Cardiol 10 1987 314 320
7. R. Beasley D.A. Smith D.J. McHaffie Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation Br Med J (Clin Res) 290 1985 9 11
8. L. Bianconi R. Boccadamo A. Pappalardo Effectiveness of intravenous propafenone for conversion of atrial fibrillation and flutter of recent onset Am J Cardiol 64 1989 335 338
9. R.D. Blevins N.Z. Kerin D. Benaderet Amiodarone in the management of refractory atrial fibrillation Arch Intern Med 147 1987 1401 1404
10. H. Blumgart The reaction to exercise of the heart affected by auricular fibrillation Heart 11 1924 49
11. L. Briggs A. Pollak R.H. Falk Assessment of left ventricular function after cardioversion of atrial fibrillation [abstr] Circulation 90 suppl 1994 I-610
12. M.A. Brodsky M.V. Orlov E.V. Capparelli Magnesium therapy in new-onset atrial fibrillation Am J Cardiol 73 1994 1227 1229
13. M. Brodsky R. Saini R. Bellinger Comparative effects of the combination of digoxin and dl-sotalol therapy versus digoxin monotherapy for control of ventricular response in chronic atrial fibrillation Am Heart J 127 1994 572 577
14. R.W. Brown A.J. Goble Effect of propranolol on exercise tolerance in patients with atrial fibrillation Br Med J 2 1969 279 280
15. D.A. Chamberlain R.J. White M.R. Howard Plasma digoxin concentrations in patients with atrial fibrillation Br Med J 3 1970 429 432
16. G.D. Clifton M.R. Harrison A.N. DeMaria Influence of beta-adrenergic blockade upon hemodynamic response to exercise assessed by Doppler echocardiography Am Heart J 120 1990 579 585
17. J.C. Cowan P. Gardiner D.S. Reid A comparison of amiodarone and digoxin in the treatment of atrial fibrillation complicating suspected acute myocardial infarction J Cardiovasc Pharmacol 8 1986 252 256
18. D. David E. DiSegni H.V. Klein Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agent Am J Cardiol 44 1979 1378 1382
19. C. DeCarli G. Sprouse J.C. LaRosa Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin Am J Cardiol 57 1986 956 959
20. R. DiBianco J. Morganroth R.J. Freitag Effects of nadolol on the spontaneous and exercise-provoked heart rate in patients with chronic atrial fibrillation receiving stable doses of digoxin Am Heart J 108 1984 1121 1127
21. K.A. Ellenbogen V.C. Dias V.J. Plumb A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: A multicenter study J Am Coll Cardiol 18 1991 891 897
22. R.H. Falk Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation Ann Intern Med 111 1989 107 111
23. R.H. Falk A.A. Knowlton N.J. Battinelli Reproducibility of the heart rate response to exercise in patients with atrial fibrillation J Am Coll Cardiol 11 suppl A 1988 247A
24. R.H. Falk A.A. Knowlton S. Bernard Digoxin for converting recent-onset atrial fibrillation-a randomized, double-blind trial Ann Intern Med 106 1987 503 506
25. S. Goldman P. Probst A. Selzer Inefficacy of therapeutic serum levels of digoxin in controlling the ventricular rate in atrial fibrillation Am J Cardiol 35 1975 651 655
26. J.S. Graettinger R.A. Carleton J.J. Muenster Circulatory consequences of changes in cardiac rhythm produced in patients by transthoracic direct-current shock J Clin Invest 43 1964 2290 2302
27. J.V. Hays J.K. Gilman B.J. Rubal Effect of magnesium sulfate on ventricular rate control in atrial fibrillation Ann Emerg Med 24 1994 61 64
28. L.N. Horowitz S.R. Spielman A.M. Greenspan Use of amiodarone in the treatment of persistent and paroxysmal atrial fibrillation resistant to quinidine therapy J Am Coll Cardiol 6 1985 1402 1407
29. Z.Y. Hou M.S. Chang C.Y. Chen Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone: A randomized, digoxin-controlled study Eur Heart J 16 1995 521 528
30. S. Jull-Moller N. Edvardsson N. Rehnqvist-Alzberg Sotalol versus quinidine for the maintenance of sinus rhythm after direct-current cardioversion of atrial fibrillation Circulation 82 1990 1932 1939
31. K. Kawakubo M. Murayama T. Itai Heart rate at onset and termination of paroxysmal atrial fibrillation in apparently healthy subjects Jpn Heart J 27 1986 645 651
32. C.R. Kerr G.H. Klein J.F. Axelson Propafenone for prevention of recurrent atrial fibrillation Am J Cardiol 61 1988 914 916
33. T. Killip R.A. Baer Hemodynamic effects after reversion from atrial fibrillation to sinus rhythm by precordial shock J Clin Invest 45 1966 658 671
34. J.A.C. Knox The heart rate with exercise patients with auricular fibrillation Br Heart J 11 1949 119
35. M.D. Kraemer M. Sullivan J.E. Atwood Reproducibility of treadmill exercise data in patients with atrial fibrillation Cardiology 76 1989 234 242
36. R. Lang H. Klein E. Segni Verapamil improves exercise capacity in chronic atrial fibrillation: Double-blind crossover study Am Heart J 105 1983 820 824
37. R. Lang H.O. Klein E. Weiss Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation Chest 83 1983 491 499
38. T. Lundstrom L. Ryden Ventricular rate control and exercise performance in chronic atrial fibrillation: Effects of diltiazem and verapamil J Am Coll Cardiol 16 1990 86 90
39. G.I. Mallis G.H. Schmidt J. Lindenbaum Superior bioavailability of digoxin, solution in capsules Clin Pharmacol Ther 18 1976 761 768
40. F.I. Marcus The hazards of using type IC antiarrhythmic agent for the treatment of paroxysmal atrial fibrillation Am J Cardiol 66 1990 366 367
41. B. Margolis R.A. DeSilva B. Lown Episodic drug treatment in the management of paroxysmal arrhythmias Am J Cardiol 45 1980 621 626
42. W. Modell H. Gold H.H. Rothendler Use of digitalis to prevent exaggerated acceleration of the heart JAMA 116 1941 2241
43. F.D. Murgatroyd N.P. Curzen J. Aldergather Clinical features and drug therapy in patients with paroxysmal atrial fibrillation: Results from the CRAFT multicenter registry [abstr] J Am Coll Cardiol 21 suppl A 1993 380A
44. F.D. Murgatroyd D.M. O'Farrell J.P. Foran A multicenter double-blind crossover comparison of disopyramide, atenolol and placebo for symptomatic paroxysmal atrial fibrillation J Am Coll Cardiol 23 suppl A 1994 231A
45. F.D. Murgatroyd B. Xie S.M. Gibson The effects of digoxin in patients with paroxysmal atrial fibrillation: Analysis of Holter data from the CRAFT-1 trial [abstr] J Am Coll Cardiol 21 suppl A 1993 203A
46. L.H. Opie W.H. Frishman Y. Thadani Calcium channel antagonists (calcium entry blockers) L.H. Opie Drugs for the Heart ed 4 1995 WB Saunders Philadelphia 50 82
47. L.P. Panidis J. Morganroth C. Baessler Effectiveness and safety of oral verapamil to control exercise-induced tachycardia in patients with atrial fibrillation receiving digitalis Am J Cardiol 52 1983 1197 1201
48. M.S. Perelman W.J. McKenna E. Rowland A comparison of bepridil with amiodarone in the treatment of established atrial fibrillation Br Heart J 58 1987 339 344
49. D.W. Pitcher M. Papouchado M.A. James Twenty-four hour ambulatory electrocardiography in patients with chronic atrial fibrillation Br Med J 292 1986 594
50. E.V. Platia E.L. Michelson J.K. Porterfield Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter Am J Cardiol 63 1989 925 929
51. E.A. Raeder Circadian fluctuations in ventricular response to atrial fibrillation Am J Cardiol 66 1990 1013 1016
52. J.M. Rawles M.J. Metcalfe K. Jennings Time of occurrence, duration and ventricular rate of paroxysmal atrial fibrillation: The effect of digoxin Br Heart J 63 1990 225 227
53. A. Redfors Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation Acta Med Scand 190 1971 321 333
54. S.A. Roberts C. Diaz P.E. Nolan Effectiveness and costs of digoxin treatment for atrial fibrillation and flutter Am J Cardiol 72 1993 567 573
55. K. Robinson M.P. Frenneaux B. Stockins Atrial fibrillation in hypertrophic cardiomyopathy: A longitudinal study J Am Coll Cardiol 15 1990 1279 1285
56. A. Roth E. Harrison G. Mitani Efficacy of medium and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation Circulation 73 1986 316 324
57. E. Rowland W.J. McKenna H. Gullzer The comparative effects of diltiazem and verapamil on atrioventricular conduction and atrioventricular reentry tachycardia Circulation 52 1983 163 168
58. D.M. Salerno V.C. Dias R.E. Kleiger Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter: The diltiazem-atrial fibrillation/flutter study group Am J Cardiol 63 1989 1046 1051
59. M. Shenasa S. Denker R. Mahmud Effect of amiodarone on conduction and refractoriness of the His-Purkinje system in the human heart J Am Coll Cardiol 4 1984 105 110
60. M. Shenasha T. Kus M. Fromer Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation Am J Cardiol 62 1988 403 407
61. T.W. Smith Digitalis glycosides N Engl J Med 288 1973 719 722
62. J.S. Steinberg R.J. Katz G.B. Bren Efficacy of oral diltiazem to control ventricular response in chronic atrial fibrillation at rest and during exercise J Am Coll Cardiol 9 1987 405 411
63. C.Y. Sum A. Yacobi R. Kartzinal Kinetics of esmolol an ultrashort-acting beta-blocker, and of its major metabolite Clin Pharmacol Ther 47 1983 427 444
64. M.J. Suttorp J.H. Kingma A.H.L. Lie Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm Am J Cardiol 63 1989 693 698
65. M. Talajic S. Nattel Frequency-dependent effects of calcium antagonists on atrioventricular conduction and refractoriness: Demonstration and characterization in anesthetized dogs Circulation 74 1986 1156 1167
66. M. Talajic M. Nayebpour W. Jing Frequency-dependent effects of diltiazem on the atrioventricular node during experimental atrial fibrillation Circulation 80 1989 380 389
67. C.T. Timm A.A. Knowlton N.J. Battinelli Flecainide for heart rate control in atrial fibrillation J Am Coll Cardiol 13 1989 164A
68. L. Toivonen A. Kadish W. Kou Determinants of the ventricular rate during atrial fibrillation J Am Coll Cardiol 16 1990 1194 1200
69. I.C. Van Gelder H.J.G.M. Crijns W.H. Van Gilst Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter Am J Cardiol 64 1989 1317 1321
70. R. Wilkinson W.A. Burr A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis Am Heart J 108 1984 1160 1167
71. W. Withering An account of the foxglove and some of its medical uses 1785 Paternoster-Row London